An inhibitor of the CBP and p300 bromodomains
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

PF-CBP1

Item No. 18811

Technical Information
Formal Name
5-(3,5-dimethyl-4-isoxazolyl)-1-[2-(4-morpholinyl)ethyl]-2-[2-(4-propoxyphenyl)ethyl]-1H-benzimidazole
CAS Number
1962928-21-7
Molecular Formula
C29H36N4O3
Formula Weight
Purity
≥98%
Formulation
A crystalline solid
DMF: 30 mg/mlDMF:PBS(pH 7.2)(1:1): 0.5 mg/mlDMSO: 20 mg/mlEthanol: 20 mg/ml
λmax
223, 285 nm
SMILES
CCCOC(C=C1)=CC=C1CCC2=NC3=CC(C4=C(C)ON=C4C)=CC=C3N2CCN5CCOCC5
InChi Code
InChI=1S/C29H36N4O3/c1-4-17-35-25-9-5-23(6-10-25)7-12-28-30-26-20-24(29-21(2)31-36-22(29)3)8-11-27(26)33(28)14-13-32-15-18-34-19-16-32/h5-6,8-11,20H,4,7,12-19H2,1-3H3
InChi Key
CGWBJJZOKGZCSJ-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Cayman Chemical
    Neutrophil Biology Wall Poster

    Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.

    DOWNLOAD NOW
    Product Description

    PF-CBP1 is an inhibitor of the CBP and p300 bromodomains (IC50s = 125 and 363 nM, respectively).1 It displays greater than 100-fold selectivity for the bromodomain of CBP over those of BRD4 and a panel of other proteins.1 PF-CBP1 reduces the expression of inflammatory cytokines by LPS-stimulated primary macrophages.1 It also suppresses the expression of RGS4 (regulator of G protein signaling 4) in primary cortical neurons.1

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Piatnitski Chekler, E.L., Pellegrino, J.A., Lanz, T.A., et alTranscriptional profiling of a selective CREB binding protein bromodomain inhibitor highlights therapeutic opportunities. Chem. Biol. 22(12), 1588-1596 (2015).